CME Stock Recent News

Bitcoin-centric stocks like NVDA, CME, IBKR and ACN are poised to gain from the ongoing cryptocurrency rally.

The market is experiencing robust earnings growth, low inflation, and solid GDP figures, leading many to feel bullish despite underlying economic challenges. While valuations are high, investors are banking on an "immaculate soft landing" for growth, making high-quality dividend stocks an attractive choice. I'm gradually shifting my focus to high-yield dividend stocks, anticipating better risk/reward scenarios compared to the S&P 500 in the coming years.

Evaluate the expected performance of CME (CME) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

CHICAGO , Oct. 17, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced its new CBL Australian Carbon Credit Unit (ACCU) futures have launched and are available for trading. A total of five contracts traded as a block between Freepoint Commodities and Mercuria on October 14, 2024.

Bitcoin-centric stocks like Robinhood Markets (HOOD), NVIDIA (NVDA) and CME Group (CME) are poised to benefit from the ongoing rally.

CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Added new longs: CME Group, CompoSecure, and Mitsubishi Heavy Industries during early August market dip; exited Finning and reduced Garmin and Kongsberg due to full valuations. CME Group is undervalued with strong potential due to its monopoly-like position in derivatives markets and resilience against new competition. CompoSecure benefits from a transformative transaction with David Cote, enhancing financial structure and strategic direction, making shares attractive despite prior SPAC stigma.

Record Europe, Middle East and Africa (EMEA) ADV of 6.2M, up 30% in Q3 2024 Asia Pacific (APAC) ADV of 1.8M, up 28% LONDON and SINGAPORE , Oct. 14, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its international average daily volume (ADV) reached a record 8.4 million contracts in Q3 2024, up 29% year on year. Reflecting all trading reported outside the United States, the record volume was driven by growth across all asset classes, with the highest trading volumes coming from interest rate and equity products, which accounted for three-quarters of the growth in volume.

CME Group's dominant market position and high profitability make it a crucial player in global finance, particularly in derivatives and futures trading. The company's exceptional free cash flow margin of 60.30% and consistent dividend growth make it an attractive option for dividend investors. Despite its strong fundamentals, CME Group is currently rated as a hold due to its high valuation, with a fair value estimate of $211.27 per share.

Here's today's Final Trades from the Investment Committee.